3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase 3
1
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
9
Prostatic Neoplasms, Castration-Resistant
1
Prostatic Diseases
1
Prostate Cancer Non-Metastatic
1
Prostate Cancer Metastatic
1
Prostate Adenocarcinoma
1
Neoplasms
1
Metastatic Hormone-sensitive Prostate Cancer
1
Metastatic Castration-resistant Prostate Cancer (mCRPC)
1
Metastatic Castration-resistant Prostate Cancer
1
Genital Diseases, Male
1
Biochemically Recurrent Prostate Cancer
1
Adenocarcinoma
1
Interventions
olaparib
3
Abiraterone Acetate
3
enzalutamide
2
Docetaxel
2
radium Ra 223 dichloride
1
darolutamide
1
cabazitaxel
1
Prednisone
1
Prednisolone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Metastatic Castration-resistant Prostate Cancer
×
darolutamide
×
Clear all
NCT04237584
2022-10-07
ESCALATE
MANA RBM
Phase 3
Terminated
23 enrolled
11 charts